why choose us

Clinical Trials Search

Showing 18,100 of 132,963 result(s)
Ketamine for the Treatment for Alcohol Use Disorder in the ED

Status: Completed

Condition: Alcohol Use Disorder

Interventions: The intervention will consist of a single infusion of ketamine in the ED at a dose of 0.8mg;kg over 40 minutes.

Date: 2022-11-21

Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia

Status: Completed

Condition: Schizophrenia

Interventions: The Sonicator-1000 system will non-invasively deliver ultrasound sonications transcranially that selectively target specific areas of the brain using

Date: 2022-11-21

ADRB3 Signaling Pathway in Human Adipose Tissue

Status: NOT_YET_RECRUITING

Condition: Obesity, Prediabetes

Interventions: Single dose, 100mg oral mirabegron

Date: 2022-11-21

A Study of Giredestrant in Participants With Grade 1 Endometrial Cancer

Status: Completed

Condition: Endometrial Cancer

Interventions: Participants will receive giredestrant 30 milligrams (mg) taken orally (PO) once a day (QD) on Days 1 to 28 of each 28-day cycle for 6 cycles.
Af

Date: 2022-11-21

NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks

Status: Completed

Condition: Overweight or Obesity

Interventions: NDPP-NextGen will incorporate content on preconception;prenatal health into standard NDPP.
Participants will be encouraged to make sustainab

Date: 2022-11-21

Effect of Short-Term Prednisone Therapy on C-Reactive Protein Change in Emergency Department Patients With Acute Heart Failure and Elevated Inflammatory Markers ( CORTAHF )

Status: Completed

Condition: Acute Heart Failure

Interventions: 2 tabs of 20 mg prednisone per day during 7 days added to usual care medications

Date: 2022-11-21

Wearable Sensors for Delirium Detection at an Early Stage (WeSen_delirium)

Status: Completed

Condition: Delirium

Interventions:

Date: 2022-11-21

The Effect of Uncertainty in Heart Failure

Status: COMPLETED

Condition: Heart Failure With Reduced Ejection Fraction

Interventions: Valid and reliable questionnaires covering perceived uncertainty, self-care behaviors and quality of life will be administered.

Date: 2022-11-21

A Study to Evaluate the Efficacy and Safety of AD-209

Status: Completed

Condition: Hypertension, Essential

Interventions: PO, Once daily(QD), 8weeks

Date: 2022-11-20

Xian-Hua-Cha for Relieving Hyperlipidemia With Obesity

Status: Completed

Condition: Hyperlipidemias

Interventions: Zizyphus jujuba Mill., Nelumbo nucifera Gaertn, Citrus reticulata Blanco, Rosa rugosa Thunb., Cassia obtusifolia L., Stevioside, resistant starch, and

Date: 2022-11-20